EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The small molecule ZPD ‐2 inhibits the aggregation and seeded polymerisation of C‐terminally truncated α‐Synuclein

Samuel Peña-Díaz iD, Salvador Ventura iD

The FEBS Journal · 2024

DOI: 10.1111/febs.17310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Samuel Peña-Díaz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Hauptthemen laut MEDLINE: alpha-Synuclein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación La Marató de TV3, Spanish Ministry of Science and Innovation, ICREA-Academia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein aggregation, particularly the formation of amyloid fibrils, is associated with numerous human disorders, including Parkinson's disease. This neurodegenerative condition is characterised by the accumulation of α‐Synuclein amyloid fibrils within intraneuronal deposits known as Lewy bodies or neurites. C‐terminally truncated forms of α‐Synuclein are frequently observed in these inclusions in the brains of patients, and their increased aggregation propensity suggests a role in the disease's pathogenesis. This study demonstrates that the small molecule ZPD‐2 acts as a potent inhibitor of both the spontaneous and seeded amyloid polimerisation of C‐terminally truncated α‐Synuclein by interfering with early aggregation intermediates. This dual activity positions this molecule as a promising candidate for therapeutic development in treating synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinHumansAmyloidParkinson DiseaseProtein AggregatesProtein Aggregation, PathologicalProtein MultimerizationPolymerizationPyrazolesBenzodioxoles

Stichwörter der Autor:innen

inhibitionoligomerprotein aggregationtruncationα‐Synuclein

Substanzen

alpha-SynucleinAmyloid3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazoleProtein AggregatesSNCA protein, humanPyrazolesBenzodioxoles

Autor:innen und Institutionen

  • Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.

ORCID-Profile: Samuel Peña-Díaz, Salvador Ventura

Förderung

  • Fundación La Marató de TV3
  • Spanish Ministry of Science and Innovation
  • ICREA-Academia
  • AGAUR (Generalitat de Catalunya)
  • CERCA Programme (Generalitat de Catalunya)

Zitieren

APA

Peña-Díaz, S., & Ventura, S. (2024). The small molecule ZPD ‐2 inhibits the aggregation and seeded polymerisation of C‐terminally truncated α‐Synuclein. The FEBS Journal. https://doi.org/10.1111/febs.17310

Vancouver

Peña-Díaz S, Ventura S. The small molecule ZPD ‐2 inhibits the aggregation and seeded polymerisation of C‐terminally truncated α‐Synuclein. The FEBS Journal. 2024. doi:10.1111/febs.17310

BibTeX
@article{PeaDaz2024,
  author = {Peña-Díaz, Samuel and Ventura, Salvador},
  title = {The small molecule ZPD ‐2 inhibits the aggregation and seeded polymerisation of C‐terminally truncated α‐Synuclein},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17310}
}
Kostenlos starten →